Isomacne

Isotretinoin, the active ingredient in Isomacne, is a retinoid presented as an oral dosage form for oral use. It is indicated for the treatment of severe recalcitrant nodular acne in patients who have not responded to conventional therapies.

GNH USA supplies Isomacne as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers. Its global distribution network ensures timely delivery across Europe, Asia, Africa and the Americas.

Isotretinoin is used in dermatology to target severe forms of acne that are resistant to standard therapies.

- Severe recalcitrant nodular acne: markedly reduces inflammatory lesions and prevents formation of new nodules. - Severe nodular acne vulgaris: clears extensive acne lesions when topical and oral antibiotics have failed. - Moderate to severe acne vulgaris: improves overall skin appearance in patients unresponsive to conventional regimens.

Isotretinoin may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dry skin and mucous membranes: increased dryness of skin, lips and eyes. - Cheilitis: painful cracking and inflammation of the lips. - Xerosis: generalized skin dryness and scaling. - Photosensitivity: heightened skin reaction to sunlight. - Headache: mild to moderate head discomfort. - Myalgia: muscle aches or stiffness.

Serious or Rare Side Effects: - Teratogenicity: severe birth defects if exposure occurs during pregnancy. - Depression or suicidal ideation: mood changes requiring immediate medical attention. - Inflammatory bowel disease: rare onset of ulcerative colitis or Crohn's disease. - Hepatotoxicity: elevated liver enzymes indicating liver stress. - Hyperlipidemia: significant increase in triglycerides or cholesterol. - Visual disturbances: night blindness or decreased visual acuity.

Before initiating isotretinoin therapy, several safety considerations should be observed.

- Pregnancy prevention: ensure effective contraception and negative pregnancy test before starting. - Liver monitoring: obtain baseline liver function tests and repeat periodically. - Lipid monitoring: check fasting lipid profile prior to treatment and during therapy. - Vitamin A intake: avoid concurrent high‑dose vitamin A supplements. - Sun protection: advise patients to use sunscreen and protective clothing. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Isotretinoin can interact with other medicines, altering efficacy or increasing risk of adverse events.

Major Interactions (Avoid): - Tetracyclines: combined use may increase risk of intracranial hypertension. - Vitamin A supplements: additive teratogenic risk and toxicity. - Systemic corticosteroids: may exacerbate psychiatric side effects.

Moderate Interactions (Monitor Closely): - Oral contraceptives: isotretinoin may reduce contraceptive effectiveness; advise backup methods. - Anticoagulants (e.g., warfarin): potential for altered coagulation parameters. - Azole antifungals: may increase isotretinoin plasma levels. - Phenobarbital and other enzyme inducers: may decrease isotretinoin concentrations.